Access
To read this story in full you will need to login or make a payment (see right).
Review
Nature Medicine 7, 781 - 787 (2001)
doi:10.1038/89901
Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
David Kirn1,4, Robert L. Martuza2 & James Zwiebel3
Abstract
In the search for novel cancer therapies that can be used in conjunction with existing treatments, one promising area of research is the use of viral vectors and whole viruses. This review describes the underlying biological principles and current status of the field, outlines approaches for improving clinical effectiveness and discusses the unique safety and regulatory issues surrounding viral therapies.
To read this story in full you will need to login or make a payment (see right).
